These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 26304938

  • 1. Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation.
    Jaffer IH, Stafford AR, Fredenburgh JC, Whitlock RP, Chan NC, Weitz JI.
    J Am Heart Assoc; 2015 Aug 24; 4(8):e002322. PubMed ID: 26304938
    [Abstract] [Full Text] [Related]

  • 2. Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve-Induced Thrombin Generation.
    Jaffer IH, Fredenburgh JC, Stafford A, Whitlock RP, Weitz JI.
    Ann Thorac Surg; 2020 Aug 24; 110(2):582-590. PubMed ID: 31877292
    [Abstract] [Full Text] [Related]

  • 3. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP, Abid AR, Zafar H, Khan JS.
    Ann Thorac Cardiovasc Surg; 2009 Feb 24; 15(1):10-7. PubMed ID: 19262444
    [Abstract] [Full Text] [Related]

  • 4. Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits.
    Yau JW, Liao P, Fredenburgh JC, Roberts RS, Weitz JI.
    Thromb Haemost; 2014 Jul 03; 112(1):79-86. PubMed ID: 24573541
    [Abstract] [Full Text] [Related]

  • 5. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q, Kim JE, Hyun J, Han KS, Kim HK.
    Thromb Res; 2013 Jul 03; 132(1):e70-5. PubMed ID: 23769659
    [Abstract] [Full Text] [Related]

  • 6. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
    Grzymala-Lubanski B, Svensson PJ, Renlund H, Jeppsson A, Själander A.
    Heart; 2017 Feb 03; 103(3):198-203. PubMed ID: 27590664
    [Abstract] [Full Text] [Related]

  • 7. Dabigatran versus warfarin in patients with mechanical heart valves.
    Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van de Werf F, RE-ALIGN Investigators.
    N Engl J Med; 2013 Sep 26; 369(13):1206-14. PubMed ID: 23991661
    [Abstract] [Full Text] [Related]

  • 8. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN).
    Van de Werf F, Brueckmann M, Connolly SJ, Friedman J, Granger CB, Härtter S, Harper R, Kappetein AP, Lehr T, Mack MJ, Noack H, Eikelboom JW.
    Am Heart J; 2012 Jun 26; 163(6):931-937.e1. PubMed ID: 22709744
    [Abstract] [Full Text] [Related]

  • 9. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.
    Am J Hematol; 2012 Apr 26; 87(4):384-7. PubMed ID: 22367852
    [Abstract] [Full Text] [Related]

  • 10. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
    Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, Hantel S, Feuring M, Kreuzer J.
    Thromb Haemost; 2015 Jul 26; 114(1):150-7. PubMed ID: 25739680
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation.
    Scott KA, Amirehsani KA.
    J Am Assoc Nurse Pract; 2015 Apr 26; 27(4):190-6. PubMed ID: 25066647
    [Abstract] [Full Text] [Related]

  • 12. [Thrombosis of a mechanical prosthetic mitral valve during dabigatran treatment].
    Thomsen JH, Kjaergaard J, Saust LT, Wachtell K, Hassager C.
    Ugeskr Laeger; 2014 Mar 17; 176(12A):. PubMed ID: 25350892
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
    McKellar SH, Abel S, Camp CL, Suri RM, Ereth MH, Schaff HV.
    J Thorac Cardiovasc Surg; 2011 Jun 17; 141(6):1410-6. PubMed ID: 21429525
    [Abstract] [Full Text] [Related]

  • 14. Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
    Pallisgaard JL, Lindhardt TB, Hansen ML, Schjerning AM, Olesen JB, Staerk L, Torp-Pedersen C, Gislason GH.
    PLoS One; 2015 Jun 17; 10(10):e0141377. PubMed ID: 26513589
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
    Wong CS, Batchelor K, Bua J, Newall F.
    Thromb Res; 2011 Oct 17; 128(4):331-4. PubMed ID: 21620442
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW, Zimetbaum PJ.
    Expert Rev Cardiovasc Ther; 2013 Nov 17; 11(11):1461-71. PubMed ID: 24147516
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.